Treatment of severe intermittent claudication with pentoxifylline: A 40-week, controlled, randomized trial

Angiology

Volumn 53, Issue SUPPL. 1, 2002, Pages

  Cesarone, M R ^a   Belcaro, G ^a   Nicolaides, A N ^a   Griffin, M ^a   De Sanctis, M T ^a   Incandela, L ^a   Geroulakos, G ^a   Ramaswami, G ^a   Cazaubon, M ^a   Barsotti, A ^a   Vasdekis, S ^a   Bavera, P ^a   Ippolito, E ^a  

^a PAP/PEA Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; PENTOXIFYLLINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EXERCISE TOLERANCE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; WALKING;

AGED; BLOOD PRESSURE; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PENTOXIFYLLINE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VASODILATOR AGENTS; WALKING;

EID: 0036171279     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Efficiency of a new prostaglandin E regimen in outpatients with severe intermittent claudication: Results of a multicenter, placebo-controlled double-blind trial
2. Second European Consensus
3. Intermittent claudication: Be conservative
4. A review of the clinical effectiveness of exercise therapy for intermittent claudication
5. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels
6. Value of supervised exercise program for therapy of arterial claudication
7. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV
8. Changes of walking distance in patients with intermittent claudication during six months intensive physical training
9. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease
10. Planning clinical trials evaluating treatment in peripheral vascular disease due to atherosclerosis
11. Carotid plaque, intima-media thickness, cardiovascular risk factors and prevalent cardiovascular disease in men and women. British Regional Heart Study
12. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disease
13. Oxpentifylline treatment of venous ulcers of the leg
14. Oxpentifylline: Effects on red cell deformability and oxygen availability from the blood in intermittent claudication